Cargando…

Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis

INTRODUCTION: Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). However, the cost of IVIg is high. Higher doses of IVIg are associated with a more insupportable financial burden to paediatric patients’ families and may produc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiangge, Zhang, Miaomiao, Zhang, Xiaohan, Zhao, Peidong, Zhai, Wensheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Haematology (Incl Blood Transfusion)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314640/ https://www.ncbi.nlm.nih.gov/pubmed/37385744 http://dx.doi.org/10.1136/bmjopen-2023-071644

Ejemplares similares

Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial
por: Pell, Julie, et al.
Publicado: (2018)

Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation
por: Cowan, Juthaporn, et al.
Publicado: (2015)

Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study
por: Gates, Priscilla, et al.
Publicado: (2020)

Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol
por: Shimano, Kristin A, et al.
Publicado: (2021)

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
por: Blade, Joan, et al.
Publicado: (2018)

Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
por: Coulson, Amy Beth, et al.
Publicado: (2022)

Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review
por: Shah, Akshay, et al.
Publicado: (2019)

MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia
por: Brown, Sarah, et al.
Publicado: (2021)

Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)
por: Abdoellakhan, Rahat A, et al.
Publicado: (2018)

Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study)
por: Lasocki, Sigismond, et al.
Publicado: (2021)

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A
por: Donners, Anouk, et al.
Publicado: (2023)

ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission
por: Marks, David I, et al.
Publicado: (2023)

Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol
por: Terakura, Seitaro, et al.
Publicado: (2020)

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial
por: Menne, Tobias, et al.
Publicado: (2022)

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study
por: Heijdra, Jessica M, et al.
Publicado: (2022)

Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol
por: Tang, Xiao-Yi, et al.
Publicado: (2016)

TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023)

Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol
por: Cantadori, Lucas Oliveira, et al.
Publicado: (2022)

Effects of vaccines in patients with sickle cell disease: a systematic review protocol
por: Wiyeh, Alison Beriliy, et al.
Publicado: (2018)

Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery
por: Lam, Ching, et al.
Publicado: (2019)

Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults
por: Tritschler, Tobias, et al.
Publicado: (2020)

Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study
por: Cohen, Kenneth Roy, et al.
Publicado: (2022)

Development of prospective hospital-based venous thromboembolism registry across India: a study protocol
por: Tabassum, Heena, et al.
Publicado: (2023)

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol
por: Schünemann, Holger J, et al.
Publicado: (2016)

Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study
por: Stokhuijzen, Eva, et al.
Publicado: (2018)

Diagnostic, preventive and therapeutic evidence in obstetrics for the implementation of patient blood management: a systematic review protocol
por: Abraha, Iosief, et al.
Publicado: (2018)

Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana
por: Anie, Kofi A, et al.
Publicado: (2017)

Iron stores in pregnant women with sickle cell disease: a protocol for a systematic review and meta-analysis
por: Aroke, Desmond, et al.
Publicado: (2019)

Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study
por: Tang, Grace H, et al.
Publicado: (2019)

PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case–control study
por: Tardy‐Poncet, Brigitte, et al.
Publicado: (2021)

Exploration of the impact of gene therapy on the lives of people with haemophilia and their families: a protocol for the mixed-methods exigency study
por: Fletcher, Simon, et al.
Publicado: (2022)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
por: Estcourt, Lise J, et al.
Publicado: (2014)

Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor–recipient continuum
por: Chassé, Michaël, et al.
Publicado: (2015)

Protocol for a feasibility randomised controlled trial of a musculoskeletal exercise intervention versus usual care for children with haemophilia
por: Hashem, Ferhana, et al.
Publicado: (2019)

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol
por: Andrés-Jensen, Liv, et al.
Publicado: (2021)

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
por: Khan, Faizan, et al.
Publicado: (2023)

Effect of cognitive–behavioural therapy on resilience and relapse in adult patients with substance use disorder: a systematic review protocol
por: Mhaidat, Ibraheem, et al.
Publicado: (2023)

Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
por: Hleuhel, Mariam Hussein, et al.
Publicado: (2019)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020)

Safety of tranexamic acid in thrombotic adverse events and seizure in patients with haemorrhage: a protocol for a systematic review and meta-analysis
por: Murao, Shuhei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l3rmrhiqafegaihgqs1vff1gid